Test Update // Chromosomal Microarray Analysis

Dear Valued Clients, 

Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes that may affect your testing experience with us.

We will be updating our offering for our Chromosomal Microarray Analysis (CMA) HR+SNP (Test Code 8665) and the test updates are as follows:

  • New and improved exon-by-exon coverage of over 5,000 clinically relevant genes and better resolution for absence of heterozygosity (AOH) <10 Mb allows for superior detection of clinically significant changes.
  • A custom Baylor Genetics and Agilent design, which allows for maximum sensitivity for detection of copy number variants, down to as small as 10kb and provides enhanced coverage for more than 5,000 genes associated with autosomal dominant, autosomal recessive X-linked disorders, and best candidate disease genes.
  • 60,000 single nucleotide polymorphism probes used for the detection of absence of heterozygosity associated with uniparental disomy or consanguinity.

If you have any questions regarding the CMA updates, please contact our client services team at 1-800-411-4636 or email us at help@baylorgenetics.com.

About Baylor Genetics’ CMA

As one of the first laboratories to offer CMA testing, Baylor Genetics has performed over 100,000 CMAs giving Baylor Genetics an unparalleled expertise in chromosomal microarray testing.

At Baylor Genetics, our CMA provides comprehensive genetic testing for the most common chromosomal conditions as well as many severe genetic conditions not detected by traditional chromosome analysis. When we receive your patient’s sample, it is analyzed against a control to determine differences in copy number variations (deletions or duplications). The location and type of change will often determine the cause of your patient’s health condition.

Previous Post
Test Update // Relaunch of BluePrint Panel
Next Post
What is Whole Exome Sequencing?